A detailed history of Hunter Perkins Capital Management, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Hunter Perkins Capital Management, LLC holds 17,241 shares of ATAI stock, worth $21,378. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,241
Previous 19,241 10.39%
Holding current value
$21,378
Previous $38,000 39.47%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$1.27 - $2.6 $2,540 - $5,200
-2,000 Reduced 10.39%
17,241 $23,000
Q3 2023

Oct 19, 2023

BUY
$1.27 - $2.28 $24,436 - $43,869
19,241 New
19,241 $25,000
Q4 2022

Jan 17, 2023

BUY
$2.38 - $3.55 $18,016 - $26,873
7,570 Added 48.31%
23,241 $61,000
Q1 2022

Apr 27, 2022

BUY
$4.66 - $7.66 $73,026 - $120,039
15,671 New
15,671 $80,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $206M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Hunter Perkins Capital Management, LLC Portfolio

Follow Hunter Perkins Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Perkins Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Perkins Capital Management, LLC with notifications on news.